The Joint Blog

MARCH 16, 2020

For the study researchers examined the use of marijuana over a 12-month period in a cohort of patients with chronic diseases, such as HIV, epilepsy, and fibromyalgia. The aim of the study was to assess the psychological safety and QoL of patients with chronic diseases who self-medicate with cannabis over time.

Patients 49

Patients Marijuana Epilepsy Treatment 49

Cannabis Law Report

MAY 6, 2022

The FDA explains it is monitoring the selling of CBD and Delta-8 THC products out of a growing safety concern. In short, the FDA has not evaluated or logged all dangerous side effects or safety concerns. Since 2015, the FDA has sent warning letters to companies allegedly illegally selling unapproved cannabinoid (CBD) products.

THC 52

THC CBD Media Food 52

Miss Marijuana

JUNE 7, 2019

Its positive effects are making waves in the medical community for patients with untreatable diseases and chronic pain, like Epilepsy , Parkinson’s and Multiple Sclerosis. 3. Testing process because safety y’all. You’re probably thinking to yourself what’s the catch? The solvent is a non-toxic fluid CO2.

Oil 69

Oil CBD Digestion Chronic Pain 69

MMJ Recs

OCTOBER 2, 2023

Common qualifying conditions include chronic pain, cancer, HIV/AIDS, multiple sclerosis, epilepsy, and glaucoma, among others. These dispensaries prioritize patient education and safety, providing a professional and comfortable experience for all visitors.

Dispensary 52

Dispensary Patients Environment Conditions 52

Cannabis Law Report

AUGUST 19, 2019

The Therapeutic Goods Administration (TGA), Australia’s medicines regulatory body (akin to the FDA in the USA and EMA in Europe), is currently collecting some potentially useful information from doctors prescribing medicinal cannabis around the progress of their patients.

Medicine 45

Medicine Patients Clinical Trials Access 45

Marijuana Lawyer Blog

SEPTEMBER 14, 2018

No one is against child safety, so implying that one side is not thinking of the safety of children is a sure way to win some easy points. Food & Drug Administration is one designed specifically for children with severe forms of epilepsy. Call us at 714-937-2050. 10, 2018, Los Angeles Times.

Marijuana 40

Marijuana Dispensary Medicine Safety 40

Veriheal

AUGUST 31, 2020

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. About Evan: Evan is an undergraduate student (undecided major) in the College of Liberal Arts at Tufts University. .

Research and Development 117

Research and Development Education Agriculture Patients 117

Veriheal

MAY 2, 2023

Aside from isolating and synthesizing cannabis compounds and proving the plant’s medicinal potential, he also invested his efforts into proving that cannabis can treat autoimmune diseases and epilepsy. He also played a pivotal role in the development of the first FDA-approved CBD-based medication for epilepsy patients, Epidiolex.

Research and Development 96

Research and Development Epilepsy Cannabinoids Medicine 96

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Refractory paediatric epilepsy. At the same time, the outlook on cannabis research data is largely positive. Conclusions.

Research and Development 52

Research and Development Medicine Access Media 52

WeedAdvisor

AUGUST 26, 2019

While the law currently only allows for CBD products to be imported by licensed patients with severe epilepsy, this could soon change. Eligible recipients can import a fixed amount of cannabis every year, at which point the prescription would require renewal. The THC Controversy. .

Strains 45

Strains Cultivation THC Epilepsy 45

Cannabis Law Report

OCTOBER 26, 2019

Sponsors must also ensure compliance with the relevant guidelines as to good clinical practice and safety monitoring and reporting, and ensure that the use of personal information complies with the Privacy Act 1988. Failure to notify the TGA can lead to removal of the product from the ARTG as well as civil and criminal penalties.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

The Cannigma

MARCH 12, 2021

And in my belief, it should be cannabis, because of the safety profile, number one. So, obviously, the person who’s taking cannabis for Parkinson’s, or epilepsy, or cancer is a very different type of patient than the person who’s taking it for wellness as say, a supplement, which does overlap with many rec users.

Legalization 128

Legalization Patients Education Dispensary 128

Weedistry

MARCH 8, 2019

In 2018, medical cannabis became legal in the UK after a nationwide outpouring of support for two young boys who rely on cannabis oil to treat their severe and rare forms of epilepsy, but lingering concerns around the safety and efficiency of the medicine mean that access is still heavily restricted. THC – between 2015 and 2017.

Oil 40

Oil Treatment Patients THC 40

SMPL

AUGUST 14, 2019

Because CBD exists as an FDA-approved epilepsy drug, Epidiolex, creating a regulatory framework is more complicated. That’s why, he said, FDA is “focusing on a different CBD: Collect Better Data.”. “We If there are data or studies that are relevant to the safety of particular uses of CBD, we want to see them.

CBD 40

CBD Research and Development Hemp Food 40